{"id":"https://openalex.org/W7220832671","doi":"https://doi.org/10.7759/cureus.117589","title":"Clinical Profile of Patients With Pseudomonas aeruginosa Infection and Antimicrobial Susceptibility Patterns of Pseudomonas aeruginosa: A Cross-sectional Prospective Study From a Tertiary Care Hospital in Central India","display_name":"Clinical Profile of Patients With Pseudomonas aeruginosa Infection and Antimicrobial Susceptibility Patterns of Pseudomonas aeruginosa: A Cross-sectional Prospective Study From a Tertiary Care Hospital in Central India","publication_year":2026,"publication_date":"2026-10-07","ids":{"openalex":"https://openalex.org/W7220832671","doi":"https://doi.org/10.7759/cureus.117589","pmid":"https://pubmed.ncbi.nlm.nih.gov/42997367","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13741895"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.117589","doi":"https://doi.org/10.7759/cureus.117589","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117589","pdf_url":"https://www.cureus.com/articles/529227-clinical-profile-of-patients-with-pseudomonas-aeruginosa-infection-and-antimicrobial-susceptibility-patterns-of-pseudomonas-aeruginosa-a-cross-sectional-prospective-study-from-a-tertiary-care-hospital-in-central-india.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/529227-clinical-profile-of-patients-with-pseudomonas-aeruginosa-infection-and-antimicrobial-susceptibility-patterns-of-pseudomonas-aeruginosa-a-cross-sectional-prospective-study-from-a-tertiary-care-hospital-in-central-india.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157812269","display_name":"Salapakshi Nagaraju","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115159","display_name":"Index Medical College, Hospital & Research Centre","ror":"https://ror.org/01jwjz832","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210115159"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Salapakshi Nagaraju","raw_affiliation_strings":["Department of Microbiology, Index Medical College, Hospital & Research Centre, Indore, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Index Medical College, Hospital & Research Centre, Indore, IND","institution_ids":["https://openalex.org/I4210115159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010844914","display_name":"Kailash Jatav","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115159","display_name":"Index Medical College, Hospital & Research Centre","ror":"https://ror.org/01jwjz832","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210115159"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kailash Jatav","raw_affiliation_strings":["Department of Microbiology, Index Medical College, Hospital & Research Centre, Indore, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Index Medical College, Hospital & Research Centre, Indore, IND","institution_ids":["https://openalex.org/I4210115159"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015994839","display_name":"Prashanth K Guddeti","orcid":"https://orcid.org/0000-0003-2290-6519","observed_orcids":["https://orcid.org/0000-0003-2290-6519"]},"institutions":[{"id":"https://openalex.org/I2802213881","display_name":"Windsor University School of Medicine","ror":"https://ror.org/05qh0gq94","country_code":"KN","type":"education","lineage":["https://openalex.org/I2802213881"]}],"countries":["KN"],"is_corresponding":false,"raw_author_name":"Prashanth K Guddeti","raw_affiliation_strings":["Department of Microbiology &amp; Immunology, Windsor University School of Medicine, Cayon, KNA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology &amp; Immunology, Windsor University School of Medicine, Cayon, KNA","institution_ids":["https://openalex.org/I2802213881"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5157812269"],"corresponding_institution_ids":["https://openalex.org/I4210115159"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.69698925,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"10","first_page":"e117589","last_page":"e117589"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12824","display_name":"Infections and bacterial resistance","score":0.04280000180006027,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10593","display_name":"Bacterial biofilms and quorum sensing","score":0.03970000147819519,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.9890000224113464},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility","display_name":"antimicrobial susceptibility","score":0.878000020980835},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":0.8880000114440918},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9739999771118164},{"id":"https://openalex.org/keywords/hospital-acquired-pneumonia","display_name":"nosocomial pneumonia","score":0.7570000290870667},{"id":"https://openalex.org/keywords/ventilator-associated-pneumonia","display_name":"ventilator-associated pneumonia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/intensive-care-unit-patients","display_name":"intensive care unit patients","score":0.7770000100135803},{"id":"https://openalex.org/keywords/clinical-profile","display_name":"clinical profile","score":0.6389999985694885},{"id":"https://openalex.org/keywords/ceftriaxone-resistance","display_name":"ceftriaxone resistance","score":0.8600000143051147},{"id":"https://openalex.org/keywords/ceftazidime-resistance","display_name":"ceftazidime resistance","score":0.8849999904632568},{"id":"https://openalex.org/keywords/cefepime-resistance","display_name":"cefepime resistance","score":0.7120000123977661},{"id":"https://openalex.org/keywords/piperacillin-tazobactam-resistance","display_name":"piperacillin-tazobactam resistance","score":0.847000002861023},{"id":"https://openalex.org/keywords/levofloxacin-resistance","display_name":"levofloxacin resistance","score":0.9179999828338623},{"id":"https://openalex.org/keywords/polymyxin-b","display_name":"polymyxin B","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9746000170707703},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.7692000269889832},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.5651999711990356},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.5141000151634216},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.492900013923645},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.388700008392334},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.32679998874664307},{"id":"https://openalex.org/C2991842025","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Tertiary care","level":2,"score":0.31700000166893005},{"id":"https://openalex.org/C2776040555","wikidata":"https://www.wikidata.org/wiki/Q19903321","display_name":"Antimicrobial stewardship","level":4,"score":0.3037000000476837},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.29989999532699585},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2944999933242798},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.27959999442100525},{"id":"https://openalex.org/C3017595490","wikidata":"https://www.wikidata.org/wiki/Q17006263","display_name":"University hospital","level":2,"score":0.25690001249313354}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.117589","doi":"https://doi.org/10.7759/cureus.117589","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117589","pdf_url":"https://www.cureus.com/articles/529227-clinical-profile-of-patients-with-pseudomonas-aeruginosa-infection-and-antimicrobial-susceptibility-patterns-of-pseudomonas-aeruginosa-a-cross-sectional-prospective-study-from-a-tertiary-care-hospital-in-central-india.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmid:42997367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42997367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13741895","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13741895/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.7759/cureus.117589","doi":"https://doi.org/10.7759/cureus.117589","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117589","pdf_url":"https://www.cureus.com/articles/529227-clinical-profile-of-patients-with-pseudomonas-aeruginosa-infection-and-antimicrobial-susceptibility-patterns-of-pseudomonas-aeruginosa-a-cross-sectional-prospective-study-from-a-tertiary-care-hospital-in-central-india.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220832671.pdf","grobid_xml":"https://content.openalex.org/works/W7220832671.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2115354303","https://openalex.org/W2127001823","https://openalex.org/W2258661746","https://openalex.org/W2588657365","https://openalex.org/W2626613401","https://openalex.org/W2948357077","https://openalex.org/W4213143646","https://openalex.org/W4383341838","https://openalex.org/W4390640818","https://openalex.org/W4394806428","https://openalex.org/W4406301064"],"related_works":["https://openalex.org/W7128962187","https://openalex.org/W2135670552","https://openalex.org/W2218428325","https://openalex.org/W2115354303","https://openalex.org/W2410682262","https://openalex.org/W4416239919","https://openalex.org/W3116955974","https://openalex.org/W4385152569","https://openalex.org/W7219116089","https://openalex.org/W4234517537"],"abstract_inverted_index":{"Background:":[0],"Pseudomonas":[1],"aeruginosa":[2,52,115,177,288],"is":[3,23],"an":[4],"important":[5],"healthcare-associated":[6],"opportunistic":[7],"pathogen":[8],"in":[9,63,68,78],"healthcare":[10],"settings,":[11],"particularly":[12,20,295],"among":[13,296],"critically":[14],"ill":[15],"and":[16,31,54,87,131,148,193,204,228,237,242,246,263,283,304,308,316],"hospitalized":[17],"patients.Multidrug":[18],"resistance,":[19,22],"carbapenem":[21],"a":[24,64,172,290],"major":[25],"problem":[26],"that":[27],"restricts":[28],"treatment":[29],"options":[30],"increases":[32],"morbidity":[33],"rates":[34],"for":[35,313],"patients":[36,49,118,202,206],"admitted":[37],"to":[38,43,94,144,168,240],"intensive":[39],"care.This":[40],"study":[41,75,97],"aimed":[42],"evaluate":[44],"the":[45,56,61,79,101,138,164,213,253,318],"clinical":[46,111,215],"profile":[47],"of":[48,60,81,108,113,119,174,209,320],"with":[50,163,223],"P.":[51,114,176,287],"infection":[53,306],"determine":[55],"antimicrobial":[57,132,219,261,292,302],"susceptibility":[58,133],"pattern":[59],"isolates":[62,112,197],"tertiary":[65],"care":[66],"hospital":[67],"Central":[69],"India.Methods:":[70],"A":[71],"hospital-based,":[72],"cross-sectional":[73],"prospective":[74],"was":[76,98,135,212,221,244],"conducted":[77],"Department":[80],"Microbiology,":[82],"Index":[83],"Medical":[84],"College,":[85],"Hospital":[86],"Research":[88],"Centre,":[89],"Indore,":[90],"from":[91,117,183,200],"January":[92],"2023":[93,146],"December":[95],"2025.The":[96],"approved":[99],"by":[100,137,187,232],"Institutional":[102],"Ethics":[103],"Committee":[104],"(ref.no.:":[105],"MU/Research/EC/Ph.D/2023/028).A":[106],"total":[107,173],"171":[109,175],"non-duplicate":[110],"obtained":[116,199],"all":[120],"age":[121],"groups":[122],"were":[123,125,151,181,198,258],"included.Isolates":[124],"identified":[126],"using":[127,153],"standard":[128],"phenotypic":[129],"methods,":[130],"testing":[134],"performed":[136],"Kirby-Bauer":[139],"disk":[140],"diffusion":[141],"method":[142],"according":[143],"CLSI":[145],"guidelines.Clinical":[147],"laboratory":[149],"data":[150],"analyzed":[152],"IBM":[154],"SPSS":[155],"Statistics,":[156],"version":[157],"27.0":[158],"(IBM":[159],"Corp.,":[160],"Armonk,":[161],"USA),":[162],"chi-square":[165],"test":[166],"used":[167],"assess":[169],"associations.Results:":[170],"From":[171],"isolates,":[178],"72":[179],"(42.1%)":[180],"recovered":[182],"respiratory":[184],"specimens,":[185],"followed":[186,231],"pus/wound":[188],"swabs":[189],"(24.0%),":[190],"urine":[191],"(16.4%),":[192],"blood":[194],"(10.5":[195],"%).Most":[196],"ICU":[201,264,297],"(69.6%),":[203],"male":[205],"constituted":[207],"65.5%":[208],"cases.Hospitalacquired/ventilator-associated":[210],"pneumonia":[211],"commonest":[214],"presentation":[216],"(35.7%).The":[217],"highest":[218],"resistance":[220,255,262,293],"observed":[222,259],"ceftriaxone":[224],"(69.0%),":[225],"ceftazidime":[226],"(60.2%),":[227],"cefepime":[229],"(57.9%),":[230],"aztreonam":[233],"(55.6%),":[234],"piperacillin-tazobactam":[235],"(53.8%),":[236],"levofloxacin":[238],"(49.7%).Resistance":[239],"imipenem":[241],"meropenem":[243],"44.4%":[245],"40.4%,":[247],"respectively,":[248],"whereas":[249],"polymyxin":[250],"B":[251],"showed":[252,289],"lowest":[254],"(2.3%).Significant":[256],"associations":[257],"between":[260],"stay,":[265],"prior":[266],"antibiotic":[267],"exposure,":[268],"mechanical":[269],"ventilation,":[270],"urinary":[271],"catheterization,":[272],"central":[273],"line/IV":[274],"catheter":[275],"use,":[276],"diabetes":[277],"mellitus,":[278],"COPD,":[279],"chronic":[280],"kidney":[281],"disease,":[282],"immunocompromised":[284],"status":[285],"(p<0.05).Conclusion:":[286],"substantial":[291],"burden,":[294],"patients.Regular":[298],"local":[299],"antibiogram":[300],"surveillance,":[301],"stewardship,":[303],"stringent":[305],"prevention":[307],"control":[309],"measures":[310],"are":[311],"essential":[312],"optimizing":[314],"therapy":[315],"limiting":[317],"emergence":[319],"resistant":[321],"strains.":[322]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-08T00:00:00"}